Suzhou Rayshape Intelligence Technology Co., Ltd. has officially declared the successful closure of its Pre-B round funding, raising tens of millions of yuan. This financing endeavor was co-led by the Xingqi Fund, a subsidiary of Falcon Investment, alongside Xieli Investment. Dongzheng Capital joined as a follow-on investor, while Index Capital acted as the exclusive financial advisor for this round.

The capital raised will be predominantly allocated towards product innovation and the expansion of its global footprint. Established in 2019, Rayshape Intelligence has carved out a niche in dental 3D printing and comprehensive solutions, boasting robust in-house R&D capabilities and a diverse product portfolio. Presently, its international operations span over 70 countries, fostering collaborative ties with more than 100 renowned overseas dental firms.

The Xingqi Fund, under the aegis of Falcon Capital and the lead investor in this round, expressed confidence in the commitment and growth prospects of the Rayshape Intelligence team. Xieli Investment highlighted dentistry as a pivotal application domain for 3D printing, projecting that Rayshape Intelligence is poised to emerge as a frontrunner in its specialized market segment.

Following prior investments, Rayshape Intelligence has expedited the introduction of groundbreaking products and witnessed exponential growth in its overseas ventures. This latest infusion of capital is set to further fuel its trajectory of development.